Literature DB >> 1487229

Tolerance and pharmacokinetics of propacetamol, a paracetamol formulation for intravenous use.

M Depré1, A van Hecken, R Verbesselt, T B Tjandra-Maga, M Gerin, P J de Schepper.   

Abstract

In 12 healthy volunteers, paracetamol pharmacokinetics were compared following administration of 1 g propacetamol HCl given intravenously over a 15-min period and 500 mg paracetamol given orally. Mean +/- SD total AUC (microgram/ml.h) following the iv formulation was significantly (P < 0.01) greater than following oral paracetamol (25.53 +/- 4.27 vs 21.04 +/- 4.49) corresponding to a mean oral bioavailability of paracetamol of 82.2 +/- 9.4%. Between 1 and 2 h after administration, paracetamol plasma concentrations became very similar following both formulations. In another study, 2 g propacetamol HCl was given both as a 15-min infusion and as a 2-min bolus injection to six healthy volunteers. Contrary to mild to moderate local discomfort experienced during the 2-min bolus injection, the 15-min infusion was well tolerated without any complaints reported.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1487229     DOI: 10.1111/j.1472-8206.1992.tb00119.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  14 in total

1.  Clinically significant hemodynamic alterations after propacetamol injection in the emergency department: prevalence and risk factors.

Authors:  June-Il Bae; Shin Ahn; Yoon-Seon Lee; Won Young Kim; Jae Ho Lee; Bum Jin Oh; Kyung Soo Lim
Journal:  Intern Emerg Med       Date:  2016-05-10       Impact factor: 3.397

2.  A mechanistic approach for the scaling of clearance in children.

Authors:  Andrea N Edginton; Walter Schmitt; Barbara Voith; Stefan Willmann
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  Development and evaluation of a generic physiologically based pharmacokinetic model for children.

Authors:  Andrea N Edginton; Walter Schmitt; Stefan Willmann
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Effect of multifaceted intervention promoting early switch from intravenous to oral acetaminophen for postoperative pain: controlled, prospective, before and after study.

Authors:  C Ripouteau; O Conort; J P Lamas; G R Auleley; G Hazebroucq; P Durieux
Journal:  BMJ       Date:  2000-12-09

5.  Cost analysis applied to postoperative analgesia regimens: a comparison between parecoxib and propacetamol.

Authors:  P Tilleul; H Weickmans; P Tan Sean; A Lienhart; M Beaussier
Journal:  Pharm World Sci       Date:  2007-02-20

6.  Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates.

Authors:  Karel Allegaert; Brian J Anderson; Gunnar Naulaers; Jan de Hoon; Rene Verbesselt; Anne Debeer; Hugo Devlieger; Dick Tibboel
Journal:  Eur J Clin Pharmacol       Date:  2004-04-08       Impact factor: 2.953

7.  Pharmacokinetics of single dose intravenous propacetamol in neonates: effect of gestational age.

Authors:  K Allegaert; C D Van der Marel; A Debeer; M A L Pluim; R A Van Lingen; C Vanhole; D Tibboel; H Devlieger
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-01       Impact factor: 5.747

8.  First Multi-gram Preparation SCP-123, A Novel Water Soluble Analgesic.

Authors:  Lei Miao; Liang Xu; Kenneth W Narducy; Mark L Trudell
Journal:  Org Process Res Dev       Date:  2009-07-17       Impact factor: 3.317

9.  A Comparative Efficacy of Propacetamol and Ketorolac in Postoperative Patient Controlled Analgesia.

Authors:  Bong Ha Heo; Ji Hun Park; Jung Il Choi; Woong Mo Kim; Hyoung Gon Lee; Soo Young Cho; Myoung Ha Yoon
Journal:  Korean J Pain       Date:  2015-07-01

10.  A comparative study of intravenous paracetamol and fentanyl for pain management in ICU.

Authors:  Mehran Kouchek; Behnam Mansouri; Majid Mokhtari; Reza Goharani; Mir Mohammad Miri; Mohammad Sistanizad
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.